The Antoine Lacassagne Cancer Center in Nice ranked among the top 100 world’s best hospitals in oncology by the American magazine Newsweek

October 9, 2020

Centre Antoine Lacassagne

Nice, October 2020 - The Antoine Lacassagne Cancer Center in Nice, France, receives the "World's Best Hospitals in Oncology 2021" label awarded by Newsweek. It ranks among the top 100 establishments specializing in oncology in the world and in the top 10 in France.

This edition of the "World's Best Specialized Hospitals 2021" ranking identifies and honors the best hospitals around the world specialized in cardiology, endocrinology and oncology.
The Newsweek’s survey was conducted among 40,000 physicians, healthcare professionals and hospital managers from more than 20 countries. The ranking is based solely on peer recommendations for specific areas of expertise from a global survey of medical professionals.

First, the professionals were asked to name the institution(s) they recommend in their specific area and, secondly, to assign a ranking position to these hospitals (top 5, top 10…). The results of the survey were then validated by a Global Board of Medical Experts.
We are very proud to be part of the top 100 world’s best hospitals in oncology, with prestigious hospitals at the top (MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center and Dana Farber Cancer Institute in the United States), thus providing undeniable legitimacy of this ranking ”. explains Prof. Emmanuel BARRANGER, Director General of the Antoine Lacassagne Cancer Center This international recognition from our peers testifies to the exemplary care at the Antoine Lacassagne Center for people with cancer thanks to the expertise of our professionals, and of our dynamism in the field of therapeutic innovation and research. Being part of the top 10 French establishments in this ranking is all the more gratifying as the Center Antoine Lacassagne was spontaneously cited, recommended and then classified by cancer specialists”.

Share this...
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin